🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To characterize safety, tolerability and to establish the maximum tolerated...
Status
Terminated
Location
University of Chicago
Start Date
2018-07-18
Trial ID
NCT03471351
Treatments Being Tested
The purpose of this study is to evaluate the safety, PK and efficacy of RP6...
Status
Completed
Location
City of Hope
Start Date
2015-09
Trial ID
NCT02567656
Treatments Being Tested
The trial is a Phase II, open label, Simon's two stage study design to eval...
Status
Completed
Location
University Multiprofile Hospital for Active Treatment "Dr Georgi Stranski" Ltd.,
Start Date
2019-11-28
Trial ID
NCT04204057
Treatments Being Tested
To characterize safety, tolerability and to establish the maximum tolerated...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-03-12
Trial ID
NCT03770000
Treatments Being Tested
This is a phase II open label, two-arm parallel design study of T-CHOP in p...
Status
Withdrawn
Location
The University of Texas MD Anderson Cancer Center
Start Date
2023-01
Trial ID
NCT05239910
Treatments Being Tested
This is a single centre, open label, randomized, two-treatment, two-period,...
Status
Completed
Location
Algorithme Pharma Inc
Start Date
2016-02
Trial ID
NCT02690727
Treatments Being Tested
To assess the anti-tumor activity and safety of Tenalisib in patients with ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2018-11-25
Trial ID
NCT03711578
Treatments Being Tested
Phase II, randomized, open-label study, designed to evaluate the preliminar...
Status
Completed
Location
High Technology Hospital Medcenter
Start Date
2021-10-13
Trial ID
NCT05021900
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of RP653...
Status
Completed
Location
Rhizen Trial Site
Start Date
2013-11
Trial ID
NCT02017613
Treatments Being Tested
This is a Phase II, open-label, single-arm, study, designed to evaluate the...
Status
Recruiting
Location
HCG City Cancer Center
Start Date
2024-03-04
Trial ID
NCT06189209
Treatments Being Tested